• Product NameStrontium ranelate
• Brief DescriptionInhibitors
• Purification95.00%
• Biological ActivityStrontium Ranelate is a bone metabolism modulator that inhibits bone resorption while maintaining bone formation. Commonly used as an antiosteoporotic.
• Target NameCalcium Channel inhibitor
• CAS No. 135459-87-9
• Calculated MW 513.49
• Formulation C12H6N2O8S2Sr
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Endocrine system
  SMILES:[H-].[H-].[H-].[H-].[Sr++].[Sr++].OC(=O)CN(CC(O)=O)C1=C(C#N)C(CC(O)=O)=C(S1)C(O)=O
  Pathways:Membrane transporter/Ion channel
  Receptor:Calcium Channel
  Boling pt:
  Melting pt:>310C
  Solubility:Ethanol: <1 mg/mL (<1 mM); Water: <1 mg/mL (<1 mM); DMSO: <1 mg/mL (<1 mM)
  Appearance:White Powder
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Kirschneck C, et al. Eur J Pharmacol. 2014 Dec 5;744:67-75.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting